Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colonoscopy | 13 | 2022 | 1397 | 2.310 |
Why?
|
Colitis, Ulcerative | 28 | 2023 | 1921 | 1.860 |
Why?
|
Crohn Disease | 22 | 2023 | 2279 | 1.400 |
Why?
|
Colorectal Neoplasms | 13 | 2024 | 6927 | 1.220 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2016 | 875 | 0.910 |
Why?
|
Gastrointestinal Hemorrhage | 4 | 2022 | 1116 | 0.890 |
Why?
|
Cathartics | 2 | 2022 | 127 | 0.880 |
Why?
|
Early Detection of Cancer | 12 | 2024 | 3196 | 0.870 |
Why?
|
Guideline Adherence | 3 | 2019 | 2218 | 0.830 |
Why?
|
Colitis, Microscopic | 5 | 2022 | 71 | 0.830 |
Why?
|
Adenoma | 5 | 2021 | 2159 | 0.740 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 109 | 0.620 |
Why?
|
Inflammatory Bowel Diseases | 9 | 2023 | 2423 | 0.560 |
Why?
|
Colonic Polyps | 2 | 2019 | 553 | 0.540 |
Why?
|
Hepatic Encephalopathy | 1 | 2017 | 143 | 0.540 |
Why?
|
Proctocolitis | 1 | 2016 | 28 | 0.520 |
Why?
|
Mesalamine | 1 | 2016 | 135 | 0.500 |
Why?
|
Telenursing | 1 | 2014 | 2 | 0.490 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6345 | 0.490 |
Why?
|
Quality Indicators, Health Care | 4 | 2019 | 1790 | 0.490 |
Why?
|
Liver Cirrhosis | 4 | 2021 | 1927 | 0.470 |
Why?
|
Nurse Anesthetists | 1 | 2014 | 24 | 0.470 |
Why?
|
Cecal Neoplasms | 1 | 2014 | 26 | 0.460 |
Why?
|
Digestive System Diseases | 1 | 2016 | 151 | 0.460 |
Why?
|
Helicobacter pylori | 2 | 2017 | 381 | 0.460 |
Why?
|
Helicobacter Infections | 2 | 2017 | 391 | 0.450 |
Why?
|
International Normalized Ratio | 1 | 2015 | 381 | 0.450 |
Why?
|
Outpatients | 2 | 2019 | 1596 | 0.440 |
Why?
|
Deep Sedation | 1 | 2014 | 118 | 0.430 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 353 | 0.420 |
Why?
|
Gastroenterology | 2 | 2018 | 580 | 0.400 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2270 | 0.400 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1288 | 0.390 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 507 | 0.380 |
Why?
|
Telephone | 1 | 2014 | 626 | 0.370 |
Why?
|
Endosonography | 1 | 2014 | 608 | 0.350 |
Why?
|
Inpatients | 2 | 2022 | 2545 | 0.350 |
Why?
|
Microsatellite Instability | 1 | 2014 | 716 | 0.350 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1202 | 0.330 |
Why?
|
Continuity of Patient Care | 2 | 2020 | 1067 | 0.310 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2533 | 0.310 |
Why?
|
Conscious Sedation | 1 | 2012 | 532 | 0.300 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2252 | 0.290 |
Why?
|
Celiac Disease | 3 | 2021 | 819 | 0.290 |
Why?
|
Warfarin | 1 | 2015 | 1477 | 0.280 |
Why?
|
Patient Readmission | 2 | 2020 | 3269 | 0.280 |
Why?
|
Electronic Health Records | 3 | 2015 | 4810 | 0.270 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2014 | 940 | 0.270 |
Why?
|
Acute Disease | 1 | 2017 | 7236 | 0.270 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1178 | 0.270 |
Why?
|
Prospective Studies | 36 | 2023 | 54364 | 0.270 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 729 | 0.270 |
Why?
|
Insurance Coverage | 1 | 2017 | 1937 | 0.260 |
Why?
|
Quality Improvement | 3 | 2020 | 3801 | 0.260 |
Why?
|
Incidence | 22 | 2023 | 21339 | 0.260 |
Why?
|
Humans | 82 | 2024 | 760740 | 0.250 |
Why?
|
Risk Factors | 32 | 2023 | 74128 | 0.240 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7390 | 0.230 |
Why?
|
Mass Screening | 4 | 2021 | 5425 | 0.230 |
Why?
|
Middle Aged | 44 | 2022 | 220603 | 0.230 |
Why?
|
Length of Stay | 1 | 2017 | 6418 | 0.220 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2746 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3051 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2896 | 0.220 |
Why?
|
Aged | 29 | 2024 | 169092 | 0.220 |
Why?
|
Female | 53 | 2024 | 392203 | 0.210 |
Why?
|
Contraceptives, Oral | 2 | 2018 | 553 | 0.210 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2020 | 380 | 0.210 |
Why?
|
Anesthesia | 1 | 2014 | 1591 | 0.210 |
Why?
|
Decision Support Systems, Clinical | 1 | 2012 | 1171 | 0.210 |
Why?
|
Time Factors | 10 | 2019 | 39908 | 0.200 |
Why?
|
Quality of Health Care | 1 | 2017 | 4325 | 0.190 |
Why?
|
Adult | 39 | 2022 | 220995 | 0.190 |
Why?
|
Tooth Loss | 1 | 2023 | 200 | 0.190 |
Why?
|
Retrospective Studies | 12 | 2022 | 80583 | 0.190 |
Why?
|
Cecum | 1 | 2022 | 233 | 0.190 |
Why?
|
Ambulatory Care | 1 | 2012 | 2768 | 0.190 |
Why?
|
Information Literacy | 1 | 2020 | 11 | 0.180 |
Why?
|
Aspirin | 3 | 2020 | 3127 | 0.180 |
Why?
|
Primary Health Care | 3 | 2024 | 4677 | 0.180 |
Why?
|
Rectal Diseases | 1 | 2022 | 142 | 0.180 |
Why?
|
Bhutan | 3 | 2017 | 61 | 0.180 |
Why?
|
Physicians, Primary Care | 2 | 2024 | 618 | 0.180 |
Why?
|
Male | 30 | 2024 | 360402 | 0.170 |
Why?
|
Diet Surveys | 3 | 2020 | 1161 | 0.170 |
Why?
|
Patient Selection | 1 | 2012 | 4237 | 0.170 |
Why?
|
Glutens | 2 | 2021 | 240 | 0.170 |
Why?
|
Periodontal Diseases | 1 | 2023 | 451 | 0.170 |
Why?
|
Antibodies, Bacterial | 2 | 2017 | 1464 | 0.170 |
Why?
|
Intestinal Mucosa | 3 | 2020 | 3031 | 0.170 |
Why?
|
Quality of Life | 1 | 2021 | 13359 | 0.160 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 241 | 0.160 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5789 | 0.160 |
Why?
|
Medicare | 1 | 2017 | 6774 | 0.160 |
Why?
|
Ascites | 1 | 2021 | 338 | 0.160 |
Why?
|
Estrogen Replacement Therapy | 2 | 2018 | 1208 | 0.160 |
Why?
|
Aged, 80 and over | 12 | 2024 | 58919 | 0.160 |
Why?
|
Colitis, Lymphocytic | 1 | 2018 | 23 | 0.150 |
Why?
|
Heart Failure | 1 | 2022 | 11670 | 0.150 |
Why?
|
Colitis, Collagenous | 1 | 2018 | 25 | 0.150 |
Why?
|
Dietary Fats | 2 | 2017 | 1995 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 550 | 0.150 |
Why?
|
Dinoprostone | 1 | 2020 | 597 | 0.140 |
Why?
|
Proportional Hazards Models | 13 | 2019 | 12448 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 346 | 0.140 |
Why?
|
Suppositories | 1 | 2016 | 16 | 0.140 |
Why?
|
Melena | 1 | 2015 | 32 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2020 | 352 | 0.130 |
Why?
|
Seroepidemiologic Studies | 2 | 2017 | 398 | 0.130 |
Why?
|
Fluorocarbons | 1 | 2021 | 492 | 0.130 |
Why?
|
United States | 16 | 2020 | 72292 | 0.130 |
Why?
|
Duodenum | 1 | 2019 | 491 | 0.130 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 5493 | 0.130 |
Why?
|
Reproductive History | 2 | 2018 | 210 | 0.130 |
Why?
|
Follow-Up Studies | 15 | 2023 | 39062 | 0.130 |
Why?
|
Enema | 1 | 2016 | 141 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2019 | 442 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 249 | 0.120 |
Why?
|
Androgens | 1 | 2022 | 1285 | 0.120 |
Why?
|
Capsule Endoscopy | 1 | 2015 | 102 | 0.120 |
Why?
|
Smoking | 6 | 2022 | 9054 | 0.120 |
Why?
|
Colon, Ascending | 1 | 2014 | 14 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 587 | 0.120 |
Why?
|
Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.110 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12043 | 0.110 |
Why?
|
Nurses | 2 | 2021 | 2477 | 0.110 |
Why?
|
Topography, Medical | 1 | 2013 | 37 | 0.110 |
Why?
|
Young Adult | 10 | 2020 | 59191 | 0.110 |
Why?
|
MutS Homolog 2 Protein | 1 | 2014 | 197 | 0.110 |
Why?
|
Risk Assessment | 10 | 2020 | 23974 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2016 | 15609 | 0.110 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2014 | 97 | 0.110 |
Why?
|
Health Surveys | 7 | 2018 | 4036 | 0.110 |
Why?
|
Dietary Fiber | 2 | 2015 | 758 | 0.110 |
Why?
|
Medical Records | 1 | 2018 | 1408 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 3798 | 0.100 |
Why?
|
Boston | 3 | 2017 | 9313 | 0.100 |
Why?
|
Patient Care Management | 1 | 2016 | 302 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4028 | 0.100 |
Why?
|
Crowding | 1 | 2013 | 142 | 0.100 |
Why?
|
Databases, Factual | 2 | 2019 | 7963 | 0.100 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 346 | 0.100 |
Why?
|
Hemodynamics | 1 | 2022 | 4160 | 0.100 |
Why?
|
Viral Load | 2 | 2018 | 3325 | 0.100 |
Why?
|
Adolescent | 9 | 2020 | 88247 | 0.100 |
Why?
|
Zinc | 1 | 2015 | 687 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2013 | 0.090 |
Why?
|
DNA Mismatch Repair | 1 | 2014 | 428 | 0.090 |
Why?
|
Feeding Behavior | 2 | 2020 | 3183 | 0.090 |
Why?
|
Electronic Mail | 1 | 2012 | 213 | 0.090 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 517 | 0.090 |
Why?
|
Colitis | 1 | 2019 | 1234 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1797 | 0.090 |
Why?
|
Attitude to Computers | 1 | 2011 | 195 | 0.090 |
Why?
|
Chronic Disease | 4 | 2022 | 9310 | 0.090 |
Why?
|
Cohort Studies | 9 | 2022 | 41464 | 0.090 |
Why?
|
Diet | 3 | 2021 | 8049 | 0.090 |
Why?
|
Educational Status | 1 | 2017 | 2509 | 0.090 |
Why?
|
Program Evaluation | 1 | 2018 | 2486 | 0.080 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 835 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 899 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1808 | 0.080 |
Why?
|
Testosterone | 2 | 2022 | 2472 | 0.080 |
Why?
|
Informed Consent | 1 | 2016 | 1007 | 0.080 |
Why?
|
Rectum | 1 | 2014 | 891 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1054 | 0.080 |
Why?
|
Weight Gain | 1 | 2018 | 2349 | 0.080 |
Why?
|
Case-Control Studies | 7 | 2022 | 22153 | 0.080 |
Why?
|
HIV-1 | 2 | 2018 | 6858 | 0.080 |
Why?
|
Administration, Oral | 1 | 2016 | 4010 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10549 | 0.070 |
Why?
|
Logistic Models | 3 | 2017 | 13248 | 0.070 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2007 | 100 | 0.070 |
Why?
|
Bile Duct Diseases | 1 | 2007 | 97 | 0.070 |
Why?
|
Anemia | 1 | 2015 | 1504 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1745 | 0.070 |
Why?
|
Patient Admission | 1 | 2013 | 1365 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2016 | 3205 | 0.060 |
Why?
|
Immunoglobulin G | 2 | 2017 | 4533 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6305 | 0.060 |
Why?
|
Bile Ducts | 1 | 2007 | 282 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2328 | 0.060 |
Why?
|
Community Health Centers | 1 | 2009 | 460 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2756 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2015 | 1459 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15250 | 0.060 |
Why?
|
Pancreatic Ducts | 1 | 2007 | 329 | 0.060 |
Why?
|
Decision Making | 3 | 2024 | 3919 | 0.060 |
Why?
|
Pancreatic Diseases | 1 | 2007 | 344 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2863 | 0.060 |
Why?
|
Obesity | 2 | 2018 | 12934 | 0.060 |
Why?
|
Maine | 1 | 2024 | 146 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4583 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2057 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3820 | 0.060 |
Why?
|
Patient Participation | 2 | 2024 | 1443 | 0.060 |
Why?
|
HIV Infections | 3 | 2018 | 17342 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2909 | 0.060 |
Why?
|
Motor Activity | 1 | 2013 | 2714 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2018 | 777 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3680 | 0.050 |
Why?
|
Feces | 2 | 2020 | 1490 | 0.050 |
Why?
|
Inflammation | 2 | 2020 | 10759 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5780 | 0.050 |
Why?
|
Genotype | 2 | 2014 | 12977 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 1388 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4512 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5239 | 0.050 |
Why?
|
Gastrointestinal Transit | 1 | 2022 | 100 | 0.050 |
Why?
|
Reminder Systems | 1 | 2024 | 386 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 29601 | 0.050 |
Why?
|
Self Report | 3 | 2020 | 3727 | 0.040 |
Why?
|
Healthcare Disparities | 2 | 2013 | 3351 | 0.040 |
Why?
|
Anticoagulants | 1 | 2015 | 4785 | 0.040 |
Why?
|
Body Mass Index | 5 | 2018 | 12942 | 0.040 |
Why?
|
DNA Methylation | 1 | 2014 | 4392 | 0.040 |
Why?
|
Manometry | 1 | 2022 | 453 | 0.040 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1884 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 752 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2292 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2315 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2012 | 3077 | 0.040 |
Why?
|
Sleep | 1 | 2014 | 4764 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4570 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3301 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4790 | 0.040 |
Why?
|
Schools | 2 | 2017 | 1483 | 0.040 |
Why?
|
Constipation | 1 | 2022 | 563 | 0.040 |
Why?
|
Efficiency | 1 | 2020 | 476 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7847 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9586 | 0.030 |
Why?
|
Metagenomics | 1 | 2020 | 463 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26065 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 1033 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5430 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4309 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1937 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 686 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12333 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1139 | 0.030 |
Why?
|
Internal Medicine | 1 | 2021 | 1051 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3196 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 1864 | 0.030 |
Why?
|
Risk | 2 | 2018 | 9603 | 0.030 |
Why?
|
Smoking Cessation | 2 | 2018 | 2056 | 0.030 |
Why?
|
Splenomegaly | 1 | 2014 | 190 | 0.030 |
Why?
|
Cytokines | 2 | 2018 | 7373 | 0.030 |
Why?
|
Depression | 1 | 2012 | 8132 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 586 | 0.030 |
Why?
|
Seafood | 1 | 2015 | 393 | 0.030 |
Why?
|
Micromanipulation | 1 | 2012 | 53 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8652 | 0.020 |
Why?
|
Marital Status | 1 | 2013 | 425 | 0.020 |
Why?
|
Cytarabine | 1 | 2014 | 697 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2018 | 1355 | 0.020 |
Why?
|
Age Factors | 3 | 2013 | 18381 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2017 | 64572 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8835 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1436 | 0.020 |
Why?
|
Virus Replication | 1 | 2018 | 2427 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2024 | 3239 | 0.020 |
Why?
|
Women | 1 | 2012 | 224 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2012 | 445 | 0.020 |
Why?
|
New England | 1 | 2013 | 1050 | 0.020 |
Why?
|
Menopause | 1 | 2018 | 1645 | 0.020 |
Why?
|
Diuretics | 1 | 2013 | 611 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 645 | 0.020 |
Why?
|
Fruit | 1 | 2015 | 1158 | 0.020 |
Why?
|
Vegetables | 1 | 2015 | 1192 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1454 | 0.020 |
Why?
|
Geography | 1 | 2012 | 652 | 0.020 |
Why?
|
Stomach | 1 | 2014 | 696 | 0.020 |
Why?
|
Eosinophilia | 1 | 2014 | 559 | 0.020 |
Why?
|
Women's Health | 1 | 2019 | 2066 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 2241 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2015 | 955 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13495 | 0.020 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2012 | 432 | 0.020 |
Why?
|
Students | 1 | 2017 | 1736 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1317 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3868 | 0.020 |
Why?
|
Fatigue | 1 | 2014 | 1550 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1535 | 0.020 |
Why?
|
Poverty Areas | 1 | 2008 | 263 | 0.020 |
Why?
|
HLA Antigens | 1 | 2012 | 1327 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2013 | 14599 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4172 | 0.020 |
Why?
|
Nanotechnology | 1 | 2012 | 713 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3303 | 0.020 |
Why?
|
Epitopes | 1 | 2012 | 2501 | 0.020 |
Why?
|
Cultural Competency | 1 | 2008 | 299 | 0.010 |
Why?
|
HIV | 1 | 2012 | 1580 | 0.010 |
Why?
|
Birth Weight | 1 | 2013 | 2101 | 0.010 |
Why?
|
Breast Feeding | 1 | 2013 | 1355 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16572 | 0.010 |
Why?
|
RNA, Viral | 1 | 2012 | 2838 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2012 | 3145 | 0.010 |
Why?
|
Postmenopause | 1 | 2012 | 2511 | 0.010 |
Why?
|
Infant, Premature | 1 | 2013 | 2107 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9644 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6763 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2012 | 2092 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36157 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15702 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5863 | 0.010 |
Why?
|
Heart Diseases | 1 | 2014 | 2778 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6174 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5965 | 0.010 |
Why?
|
Life Style | 1 | 2012 | 3907 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2697 | 0.010 |
Why?
|
Urban Population | 1 | 2008 | 2034 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12966 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15908 | 0.010 |
Why?
|
Health Behavior | 1 | 2009 | 2643 | 0.010 |
Why?
|
Image Enhancement | 1 | 2007 | 2881 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23415 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17878 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5671 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42193 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10175 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4010 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26183 | 0.010 |
Why?
|
Child | 1 | 2017 | 80089 | 0.010 |
Why?
|